The primary objective of the study is to compare efficacy of metolazone and chlorothiazide as add-on therapy in patients refractory to loop diuretics with heart failure with a reduced ejection fraction (HFrEF). This will be a single-center randomized pilot study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
5
Day 1: Metolazone 5 mg PO Day 2: Metolazone 5 mg PO
Day 1: Chlorothiazide 500 mg IV Day 2: Chlorothiazide 500 mg IV
University of Virginia Health System
Charlottesville, Virginia, United States
Net urine output at 24 hours
Milliliters of urine output minus the oral plus intravenous intake
Time frame: 24 hours
Net urine output at 48 hours
Milliliters of urine output minus the oral plus IV intake
Time frame: 48 hours
Net fluid balance over 12 hours
the net fluid balance over 12 and 24 hours prior to the addition of metolazone or chlorothiazide compared to the 12 hours after addition of the study drug
Time frame: 24 hours
Net fluid balance over 24 hours
Net fluid balance over 24 hours prior to the addition of metolazone or chlorothiazide compared to the 24 hours after addition of the study drug
Time frame: 48 hours
Weight change
Change in documented weight in kg at 48 hours after starting metolazone or chlorothiazide
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.